(Q45121011)

English

Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa

scientific article published on 7 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 December 2017

Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa (English)

1 reference

Europe PubMed Central

9 December 2017

0 references

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

Anne von Gottberg

3

object named as

Anne von Gottberg

1 reference

Europe PubMed Central

9 December 2017

Keith P. Klugman

7

object named as

Keith P Klugman

1 reference

Europe PubMed Central

9 December 2017

Mignon du Plessis

2

object named as

Mignon du Plessis

1 reference

Europe PubMed Central

9 December 2017

Kedibone M Mothibeli

1

object named as

Kedibone M Mothibeli

1 reference

Europe PubMed Central

9 December 2017

4

object named as

Ellen Murphy

1 reference

Europe PubMed Central

9 December 2017

Susan K Hoiseth

5

object named as

Susan K Hoiseth

1 reference

Europe PubMed Central

9 December 2017

Gary W Zlotnick

6

object named as

Gary Zlotnick

1 reference

Europe PubMed Central

9 December 2017

language of work or name

0 references

publication date

7 December 2010

1 reference

Europe PubMed Central

9 December 2017

1 reference

Europe PubMed Central

9 December 2017

29

1 reference

Europe PubMed Central

9 December 2017

11

1 reference

Europe PubMed Central

9 December 2017

2187-2192

1 reference

Europe PubMed Central

9 December 2017

Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Meningococcal disease in South Africa, 1999-2002.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: implications for introducing PorA based vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Advances in the development of vaccines against Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

A universal vaccine for serogroup B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

World Vaccine Congress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Outbreak in France of Neisseria meningitidis B:15:P1.12 belonging to sequence type 1403

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.072

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.11.072

1 reference

Europe PubMed Central

9 December 2017

1 reference

Europe PubMed Central

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45121011&oldid=2066438330"